SCAMP3

gene
On this page

Summary

SCAMP3 (secretory carrier membrane protein 3, HGNC:10565) is a protein-coding gene on chromosome 1q22, encoding Secretory carrier-associated membrane protein 3 (O14828). Functions in post-Golgi recycling pathways.

This gene encodes an integral membrane protein that belongs to the secretory carrier membrane protein family. The encoded protein functions as a carrier to the cell surface in post-golgi recycling pathways. This protein is also involved in protein trafficking in endosomal pathways. Two transcript variants encoding different isoforms have been found for this gene.

Source: NCBI Gene 10067 — RefSeq curated summary.

At a glance

  • GWAS associations: 18
  • Clinical variants (ClinVar): 71 total
  • Druggable target: yes
  • MANE Select transcript: NM_005698

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:10565
Approved symbolSCAMP3
Namesecretory carrier membrane protein 3
Location1q22
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000116521
Ensembl biotypeprotein_coding
OMIM606913
Entrez10067

Gene structure

Transcript identifiers

Ensembl transcripts: 36 — 26 protein_coding, 7 retained_intron, 3 nonsense_mediated_decay

ENST00000302631, ENST00000355379, ENST00000462151, ENST00000465312, ENST00000472397, ENST00000478737, ENST00000480219, ENST00000490999, ENST00000497470, ENST00000714213, ENST00000714214, ENST00000714215, ENST00000714216, ENST00000714217, ENST00000714218, ENST00000714219, ENST00000714220, ENST00000714221, ENST00000714222, ENST00000714223, ENST00000714224, ENST00000880564, ENST00000880565, ENST00000880566, ENST00000880567, ENST00000880568, ENST00000880569, ENST00000880570, ENST00000880571, ENST00000880572, ENST00000929050, ENST00000929051, ENST00000929052, ENST00000929053, ENST00000945653, ENST00000945654

RefSeq mRNA: 2 — MANE Select: NM_005698 NM_005698, NM_052837

CCDS: CCDS1105, CCDS1106

Canonical transcript exons

ENST00000302631 — 9 exons

ExonStartEnd
ENSE00001881861155258826155258954
ENSE00003508700155257285155257386
ENSE00003592324155257498155257657
ENSE00004023141155260330155260450
ENSE00004023143155260537155260659
ENSE00004023145155261657155261734
ENSE00004023212155255981155256419
ENSE00004023225155256674155256791
ENSE00004023226155262086155262360

Expression profiles

Bgee: expression breadth ubiquitous, 143 present calls, max score 96.80.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 77.3840 / max 343.6707, expressed in 1827 samples.

FANTOM5 promoters (10 alternative TSS)

Promoter IDTPM avgSamples expressed
1494928.46861819
1494825.47251806
1495315.99161795
149511.87741256
149501.83411274
149521.3632959
149471.3394886
149460.7665424
149450.232493
149540.038112

Top tissues by expression

143 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right adrenal gland cortexUBERON:003582796.80gold quality
right adrenal glandUBERON:000123396.70gold quality
left adrenal glandUBERON:000123496.42gold quality
left adrenal gland cortexUBERON:003582596.32gold quality
stromal cell of endometriumCL:000225596.22gold quality
apex of heartUBERON:000209896.07gold quality
heart left ventricleUBERON:000208496.02gold quality
skin of legUBERON:000151195.88gold quality
mucosa of transverse colonUBERON:000499195.81gold quality
zone of skinUBERON:000001495.79gold quality
skin of abdomenUBERON:000141695.78gold quality
gastrocnemiusUBERON:000138895.51gold quality
granulocyteCL:000009495.47gold quality
metanephros cortexUBERON:001053395.44gold quality
adrenal glandUBERON:000236995.42gold quality
lower esophagus mucosaUBERON:003583495.32gold quality
C1 segment of cervical spinal cordUBERON:000646995.16gold quality
muscle of legUBERON:000138395.14gold quality
skeletal muscle organUBERON:001489295.09gold quality
spleenUBERON:000210695.07gold quality
hindlimb stylopod muscleUBERON:000425295.02gold quality
body of pancreasUBERON:000115094.99gold quality
right atrium auricular regionUBERON:000663194.97gold quality
placentaUBERON:000198794.91gold quality
body of stomachUBERON:000116194.87gold quality
cortex of kidneyUBERON:000122594.84gold quality
heartUBERON:000094894.80gold quality
lymph nodeUBERON:000002994.76gold quality
right lobe of thyroid glandUBERON:000111994.63gold quality
adult mammalian kidneyUBERON:000008294.60gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

28 targeting SCAMP3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-128-3P99.9571.172484
HSA-MIR-216A-3P99.9571.192505
HSA-MIR-145-5P99.9271.131836
HSA-MIR-5195-3P99.9270.921877
HSA-MIR-3681-3P99.8870.462254
HSA-MIR-370-5P99.7866.81706
HSA-MIR-613499.6365.681537
HSA-MIR-1212299.5669.331672
HSA-MIR-584-3P99.3567.691082
HSA-MIR-429199.2068.882969
HSA-MIR-92299.0267.231838
HSA-MIR-6895-3P98.7965.69996
HSA-MIR-427498.5966.10630
HSA-MIR-6887-5P98.5668.491295
HSA-MIR-6795-5P98.5268.511277
HSA-MIR-3187-3P97.3865.80904
HSA-MIR-7106-3P97.3365.33644
HSA-MIR-6736-3P96.9865.221342
HSA-MIR-132-5P96.6165.79115
HSA-MIR-7108-5P96.4266.17598
HSA-MIR-644A96.0266.52786
HSA-MIR-92095.9763.95811
HSA-MIR-6726-5P95.9763.72841
HSA-MIR-430095.8564.561003
HSA-MIR-5591-5P95.8564.761002

Literature-anchored findings (GeneRIF, showing 8)

  • Depletion of SCAMP3 in HeLa cells by inhibitory RNA accelerated degradation of epidermal growth factor receptor (EGFR) and EGF while inhibiting recycling (PMID:19158374)
  • SCAMP3 tubules reflect a manipulation of specific post-Golgi trafficking that might allow Salmonella to acquire nutrients and membrane, or to control host immune responses. (PMID:19438519)
  • SCAMP3 has a positive role in sorting into and budding of intralumenal vesicles and thereby controls the process of multivesicular endosome biogenesis. (PMID:21951651)
  • SCAMP 3 is a novel regulator of endosomal morphology and composition. (PMID:27507217)
  • The novel association of several endocytosis-associated proteins has been demonstrated, in particular, of CLTC and SCAMP3 with hepatocellular carcinoma progression. (PMID:27519163)
  • MicroRNA-27a/b-3p and PPARG regulate SCAMP3 through a feed-forward loop during adipogenesis. (PMID:31554889)
  • Secretory Carrier Membrane Protein 3 Interacts with 3A Viral Protein of Enterovirus and Participates in Viral Replication. (PMID:34378951)
  • the SCAMPs may largely function at the same sites during vesicular transport rather than in separate post-Golgi recycling pathways. (PMID:9378760)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_rerioscamp3ENSDARG00000016765
mus_musculusScamp3ENSMUSG00000028049
rattus_norvegicusScamp3ENSRNOG00000020500
drosophila_melanogasterScampFBGN0040285
caenorhabditis_elegansscm-1WBGENE00004743

Paralogs (4): SCAMP1 (ENSG00000085365), SCAMP2 (ENSG00000140497), SCAMP5 (ENSG00000198794), SCAMP4 (ENSG00000227500)

Protein

Protein identifiers

Secretory carrier-associated membrane protein 3O14828 (reviewed: O14828)

All UniProt accessions (13): O14828, A0AAQ5BHL7, A0AAQ5BHL8, A0AAQ5BHM9, A0AAQ5BHP1, A0AAQ5BHP8, A0AAQ5BHQ3, A0AAQ5BHQ9, A0AAQ5BHR3, A0AAQ5BHR7, A0AAQ5BHR8, A0AAQ5BHS3, A0AAQ5BHV0

UniProt curated annotations — full annotation on UniProt →

Function. Functions in post-Golgi recycling pathways. Acts as a recycling carrier to the cell surface.

Subunit / interactions. Interacts with NEDD4, NEDD4L and TSG101. Interacts with RNF126.

Subcellular location. Membrane.

Tissue specificity. Widely expressed, with highest expression in heart and skeletal muscle.

Post-translational modifications. Monoubiquitinated.

Similarity. Belongs to the SCAMP family.

Isoforms (2)

UniProt IDNamesCanonical?
O14828-11yes
O14828-22

RefSeq proteins (2): NP_005689, NP_443069 (=MANE)

Domains & families (InterPro)

IDNameType
IPR007273SCAMPFamily

Pfam: PF04144

UniProt features (27 total): modified residue 8, sequence variant 4, transmembrane region 4, sequence conflict 3, topological domain 2, chain 1, cross-link 1, splice variant 1, mutagenesis site 1, region of interest 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O14828-F176.990.44

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (9): 37, 41, 53, 72, 76, 83, 85, 313, 32

Mutagenesis-validated functional residues (1):

PositionPhenotype
67abolishes interaction with tsg101.

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 165 (showing top): BORCZUK_MALIGNANT_MESOTHELIOMA_UP, ENK_UV_RESPONSE_KERATINOCYTE_UP, CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN, MORF_HDAC1, GOBP_VESICLE_MEDIATED_TRANSPORT, PATIL_LIVER_CANCER, TCF4_Q5, GOBP_EXOCYTOSIS, GOCC_TRANS_GOLGI_NETWORK, BLALOCK_ALZHEIMERS_DISEASE_UP, HNF4_DR1_Q3, MORF_BUB3, GOBP_SECRETION, chr1q22, BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP

GO Biological Process (3): exocytosis (GO:0006887), post-Golgi vesicle-mediated transport (GO:0006892), protein transport (GO:0015031)

GO Molecular Function (1): ubiquitin protein ligase binding (GO:0031625)

GO Cellular Component (4): trans-Golgi network membrane (GO:0032588), recycling endosome membrane (GO:0055038), extracellular exosome (GO:0070062), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
vesicle-mediated transport1
secretion by cell1
vesicle fusion to plasma membrane1
Golgi vesicle transport1
transport1
intracellular protein localization1
establishment of protein localization1
ubiquitin-like protein ligase binding1
trans-Golgi network1
organelle membrane1
endosome membrane1
recycling endosome1
extracellular vesicle1
cellular anatomical structure1

Protein interactions and networks

STRING

920 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SCAMP3TSG101Q99816728
SCAMP3DRAM1Q8N682696
SCAMP3ENTREP3P81408489
SCAMP3KRTCAP2Q8N6L1455
SCAMP3STAM2O75886420
SCAMP3ERBB3P21860399
SCAMP3SCCPDHQ8NBX0399
SCAMP3MUC1P13931396
SCAMP3MTX1Q13505387
SCAMP3HCN3Q9P1Z3379
SCAMP3TRIM46Q7Z4K8371
SCAMP3STAMQ92783370
SCAMP3CMC1Q7Z7K0361
SCAMP3CRNNQ9UBG3350
SCAMP3TMX4Q9H1E5349

IntAct

195 interactions, top by confidence:

ABTypeScore
IFT70BIFT56psi-mi:“MI:0914”(association)0.790
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
TRDNTMEM223psi-mi:“MI:0914”(association)0.640
CD27TCAF2psi-mi:“MI:0914”(association)0.640
FAM234BABCD4psi-mi:“MI:0914”(association)0.620
SLC39A4TMEM120Bpsi-mi:“MI:0914”(association)0.530
VAMP5NBASpsi-mi:“MI:0914”(association)0.530
TMEM63AAP3D1psi-mi:“MI:0914”(association)0.530
SCAMP2SCAMP3psi-mi:“MI:0914”(association)0.530
DLK1SCAMP3psi-mi:“MI:0914”(association)0.530
NRASESYT2psi-mi:“MI:2364”(proximity)0.480
vpuSCAMP3psi-mi:“MI:0914”(association)0.460
NEDD4SCAMP3psi-mi:“MI:0407”(direct interaction)0.440
YAP1SCAMP3psi-mi:“MI:0407”(direct interaction)0.440
SCAMP3PCNApsi-mi:“MI:0915”(physical association)0.370
Tor1aip1PEX10psi-mi:“MI:0914”(association)0.350
Dync1li1SSR3psi-mi:“MI:0914”(association)0.350
Cdc16ANAPC15psi-mi:“MI:0914”(association)0.350
Cdc26psi-mi:“MI:0914”(association)0.350
CDC73SCAMP3psi-mi:“MI:0914”(association)0.350
Pcgf1SCAMP3psi-mi:“MI:0914”(association)0.350
Ercc6lRPL17psi-mi:“MI:0914”(association)0.350
NCSTNESYT2psi-mi:“MI:0914”(association)0.350
NcstnDERL1psi-mi:“MI:0914”(association)0.350

BioGRID (319): SCAMP3 (Affinity Capture-MS), SCAMP3 (Affinity Capture-MS), BCAP31 (Co-fractionation), DDOST (Co-fractionation), SCAMP3 (Co-fractionation), SCAMP3 (Co-fractionation), SCAMP3 (Co-fractionation), SCAMP3 (Affinity Capture-MS), SCAMP3 (Proximity Label-MS), SCAMP3 (Affinity Capture-MS), SCAMP3 (Affinity Capture-MS), SCAMP3 (Affinity Capture-MS), SCAMP3 (Affinity Capture-MS), SCAMP3 (Affinity Capture-MS), SCAMP3 (Affinity Capture-MS)

ESM2 similar proteins: A2YMP7, A4RE85, B2WCU2, B3M9W1, B3NDM7, B4GRI8, B4HIJ8, B4J043, B4L0H1, B4LIH0, B4MXW6, B4PD01, B4QLP9, O14828, O35609, O95070, P87148, Q0JAI9, Q0UUE1, Q1E5A9, Q29BL9, Q3T196, Q4FZQ0, Q58DR5, Q5APC0, Q5BJH7, Q5RBL0, Q5U3G6, Q60EA5, Q6GN58, Q6P301, Q6P6G5, Q6PC24, Q6Z8F5, Q75IC7, Q7F613, Q7SDN3, Q8H5X5, Q8MRQ4, Q91VU1

Diamond homologs: O14828, O15126, O15127, O35609, O77735, P56603, Q17QF8, Q28F21, Q58DF6, Q58DR5, Q5R5Z8, Q5RCY9, Q6GM42, Q6GPA8, Q6P0C7, Q8K021, Q8TAC9, Q969E2, Q9ERN0, Q9ET20, Q9JKD3, Q9JKE3, Q9JKV5, Q9LR68, Q0JAI9, Q6Z8F5, Q9SXA5, Q9SKT3, Q9M5P2, Q9C6X2, Q9ZTX0, Q60EA5

SIGNOR signaling

2 interactions.

AEffectBMechanism
EGFRunknownSCAMP3phosphorylation
EGFR“up-regulates activity”SCAMP3phosphorylation

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 211 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Neutrophil degranulation183.2×2e-03

GO biological processes:

GO termPartnersFoldFDR
regulation of long-term neuronal synaptic plasticity529.9×7e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

71 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance57
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1191 predictions. Top by Δscore:

VariantEffectΔscore
1:155256415:TGGAT:Tacceptor_gain1.0000
1:155256416:GGAT:Gacceptor_gain1.0000
1:155256417:GAT:Gacceptor_gain1.0000
1:155256420:C:CCacceptor_gain1.0000
1:155256420:C:Tacceptor_loss1.0000
1:155256421:T:Gacceptor_loss1.0000
1:155256672:AC:Adonor_gain1.0000
1:155256673:CC:Cdonor_gain1.0000
1:155256692:T:TAdonor_gain1.0000
1:155256787:AGCCA:Aacceptor_gain1.0000
1:155256788:GCCA:Gacceptor_gain1.0000
1:155256789:CCA:Cacceptor_gain1.0000
1:155256789:CCAC:Cacceptor_gain1.0000
1:155256790:CA:Cacceptor_gain1.0000
1:155256790:CAC:Cacceptor_gain1.0000
1:155256792:C:CCacceptor_gain1.0000
1:155256792:CTGT:Cacceptor_loss1.0000
1:155256794:G:GCacceptor_gain1.0000
1:155257333:T:TAdonor_gain1.0000
1:155257654:CTGC:Cacceptor_gain1.0000
1:155257657:CCTAA:Cacceptor_loss1.0000
1:155257658:CTAA:Cacceptor_loss1.0000
1:155258824:A:ACdonor_gain1.0000
1:155258825:C:CCdonor_gain1.0000
1:155258825:CA:Cdonor_gain1.0000
1:155258825:CACAT:Cdonor_gain1.0000
1:155260324:A:ACdonor_gain1.0000
1:155260325:C:CCdonor_gain1.0000
1:155260325:CTTA:Cdonor_gain1.0000
1:155260326:TTA:Tdonor_loss1.0000

AlphaMissense

2252 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:155260390:C:GA110P0.999
1:155260401:A:GL106P0.999
1:155256322:G:TA332D0.998
1:155256787:A:GW262R0.998
1:155256787:A:TW262R0.998
1:155257632:G:CN181K0.998
1:155257632:G:TN181K0.998
1:155258940:A:GW135R0.998
1:155258940:A:TW135R0.998
1:155256376:G:TA314D0.997
1:155257356:G:CF236L0.997
1:155257356:G:TF236L0.997
1:155257358:A:GF236L0.997
1:155257526:A:GW217R0.997
1:155257526:A:TW217R0.997
1:155257529:A:GC216R0.997
1:155257541:A:GC212R0.997
1:155258938:C:AW135C0.997
1:155258938:C:GW135C0.997
1:155256364:A:GF318S0.996
1:155256387:G:CS310R0.996
1:155256387:G:TS310R0.996
1:155256389:T:GS310R0.996
1:155256403:C:GR305P0.996
1:155257498:C:GR226P0.996
1:155258832:A:GW171R0.996
1:155258832:A:TW171R0.996
1:155260391:C:AK109N0.996
1:155260391:C:GK109N0.996
1:155260395:C:GR108P0.996

dbSNP variants (sampled 300 via entrez): RS1000115651 (1:155259949 G>A,C), RS1000529703 (1:155260122 TTGTG>T,TTG), RS1001015417 (1:155255542 G>A), RS1001517739 (1:155263713 AGAATCCAG>A), RS1002216533 (1:155262872 G>A), RS1002293618 (1:155256154 A>T), RS1002406489 (1:155255894 C>A), RS1002924414 (1:155262397 C>A,T), RS1003413249 (1:155257147 G>A,C), RS1003521261 (1:155260964 G>C), RS1004219344 (1:155259815 C>T), RS1004551167 (1:155257761 G>A), RS1005195769 (1:155261916 G>A), RS1005634545 (1:155261628 T>A), RS1006021983 (1:155259159 A>C,G,T)

Disease associations

OMIM: gene MIM:606913 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

18 associations (top):

StudyTraitp-value
GCST000879_41Crohn’s disease2.000000e-13
GCST004131_70Inflammatory bowel disease6.000000e-08
GCST004132_44Crohn’s disease2.000000e-07
GCST007294_124Body fat distribution (trunk fat ratio)8.000000e-35
GCST007294_3Body fat distribution (trunk fat ratio)6.000000e-21
GCST007294_50Body fat distribution (trunk fat ratio)1.000000e-15
GCST007295_17Body fat distribution (leg fat ratio)3.000000e-13
GCST007295_37Body fat distribution (leg fat ratio)7.000000e-17
GCST007295_72Body fat distribution (leg fat ratio)1.000000e-28
GCST010696_19Cortical thickness (min-P)2.000000e-10
GCST010697_10Cortical surface area (min-P)3.000000e-10
GCST010698_59Subcortical volume (min-P)9.000000e-10
GCST010699_20Brain morphology (min-P)7.000000e-10
GCST010700_5Cortical thickness (MOSTest)8.000000e-17
GCST010701_66Cortical surface area (MOSTest)1.000000e-09
GCST010702_43Subcortical volume (MOSTest)3.000000e-10
GCST010703_253Brain morphology (MOSTest)4.000000e-14
GCST90002404_428Red cell distribution width5.000000e-17

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0004341body fat distribution
EFO:0004346neuroimaging measurement
EFO:0004840cortical thickness
EFO:0009188Red cell distribution width

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL6066432 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

ChEMBL bioactivities

4 potent at pChembl≥5 of 4 total, top 4 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
8.54Kd2.915nMCHEMBL3752910
8.54ED502.915nMCHEMBL3752910
6.00Kd1012nMCHEMBL5653589
6.00ED501012nMCHEMBL5653589

PubChem BioAssay actives

2 with measured affinity, of 4 total; 2 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.

CompoundAssayTypeValueUnit
4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide2149348: Binding affinity to human SCAMP3 incubated for 45 mins by Kinobead based pull down assaykd0.0029uM
4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide2149348: Binding affinity to human SCAMP3 incubated for 45 mins by Kinobead based pull down assaykd1.0119uM

CTD chemical–gene interactions

31 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases expression, affects cotreatment, increases expression3
FR900359affects phosphorylation1
bisphenol Fincreases expression1
bufotalinincreases expression1
alpha-pineneincreases expression, increases abundance, affects cotreatment1
methacrylaldehydeaffects cotreatment, increases expression, increases abundance1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic acidincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
bisphenol Sincreases expression1
LDN 193189affects cotreatment, decreases expression1
bisphenol AFincreases expression1
Irinotecanaffects cotreatment, decreases expression1
Sunitinibincreases expression1
Acroleinaffects cotreatment, increases expression, increases abundance1
Air Pollutantsaffects cotreatment, increases abundance, increases expression1
Benzo(a)pyreneincreases methylation1
Caffeinedecreases phosphorylation1
Fluorouracilaffects cotreatment, decreases expression1
Ivermectindecreases expression1
Ozoneaffects cotreatment, increases expression, increases abundance1
Phenolsulfonphthaleinaffects cotreatment, increases expression1
Polycyclic Aromatic Hydrocarbonsaffects expression1
Seleniumaffects cotreatment, increases expression1
Smokedecreases expression1
Tobacco Smoke Pollutionincreases expression1
Valproic Acidaffects expression1
Vitamin Eaffects cotreatment, increases expression1
Aflatoxin B1increases methylation1
Volatile Organic Compoundsaffects cotreatment, increases expression1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5652390BindingBinding affinity to human SCAMP3 incubated for 45 mins by Kinobead based pull down assayNVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Crohn disease, inflammatory bowel disease